The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
Salem
Mohamed L
ML
Surgery Department and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. mohamedlabibsalem@yahoo.com
El-Demellawy
Maha
M
El-Azm
Abdel Raouf Abou
AR